Keywords: Radiomics, Data Analysis
Motivation: CT has a certain radiation exposure risks for the evaluation of the efficacy of non-small cell lung cancer (NSCLC) after concurrent chemoradiotherapy (CCRT).
Goal(s): The study aims to replace CT with delta-radiomics model from pre- and post-treatment chest MRI.
Approach: Radiomic models were developed from conventional MRI sequences taken pre and post treatment to select the optimal model and evaluate its predictive value for locally advanced lung cancer after chemoradiotherapy.
Results: The results indicated that the AUC of the T2 Delta Radiomics Model (T2Delta RM) is the best. Furthermore, DCA indicated that the T2Delta RM could provide better clinical utility than other models.
Impact: MRI-based radiomic predictive models accurately predict the post treatment response of locally advanced lung cancer to chemoradiotherapy, providing a novel assessment method that mitigates radiation exposure risks.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords